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PURPOSE. To determine genetic correlations between common myopia and primary open-angle
glaucoma (POAG).
METHODS. We tested the association of myopia polygenic risk scores (PRSs) with POAG and
POAG endophenotypes using two studies: the Australian & New Zealand Registry of
Advanced Glaucoma (ANZRAG) study comprising 798 POAG cases with 1992 controls, and
the Rotterdam Study (RS), a population-based study with 11,097 participants, in which
intraocular pressure (IOP) and optic disc parameter measurements were catalogued. PRSs
were derived from genome-wide association study meta-analyses conducted by the
Consortium for Refractive Error and Myopia (CREAM) and 23andMe. In total, 12 PRSs were
constructed and tested. Further, we explored the genetic correlation between myopia, POAG,
and POAG endophenotypes by using the linkage disequilibrium score regression (LDSC)
method.
RESULTS. We did not find significant evidence for an association between PRS of myopia with
POAG (P ¼ 0.81), IOP (P ¼ 0.07), vertical cup–disc ratio (P ¼ 0.42), or cup area (P ¼ 0.25).
We observed a nominal association with retinal nerve fiber layer (P ¼ 7.7 3 103) and a
significant association between PRS for myopia and disc area (P ¼ 1.59 3 109). Using the
LDSC method, we found a genetic correlation only between myopia and disc area (genetic
correlation [RhoG] ¼ 0.12, P ¼ 1.8 3 103), supporting the findings of the PRS approach.
CONCLUSIONS. Using two complementary approaches we found no evidence to support a
genetic overlap between myopia and POAG; our results suggest that the comorbidity of these
diseases is not influenced by common variants. The association between myopia and optic
disc size is well known and validates this methodology.
Keywords: refractive error, primary open-angle glaucoma, polygenic risk score, genetic
overlap
Myopia and primary open-angle glaucoma (POAG) arecomplex eye diseases in which both genetic and
environmental factors play a role.1,2 Myopia, or short-sighted-
ness, is the most common form of refractive error, affecting
approximately 1.4 billion people (approximately a quarter of
the world population), expected to increase to 5 billion by
2050 (half of the world population).3 By 2050, almost 1 billion
people will be affected by high myopia,3 the more severe form
of myopia, which is commonly defined as a refractive error
exceeding6 diopters (D). POAG is a heterogeneous condition
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characterized by progressive degeneration of the optic nerve
that may lead to irreversible blindness, and is often associated
with elevated intraocular pressure (IOP), the main modifiable
risk factor in POAG development and progression.4,5 It has
been estimated that by 2020, between 53 and 65 million
people will be affected by POAG.6–8
Although multiple epidemiologic studies have shown that
patients with myopia, and particularly with high myopia
(refractive error 6 D), have an increased risk of developing
POAG among other ocular comorbidities,9,10 there is conflict-
ing evidence about the relation between myopia and glaucoma.
On the one hand, various population-based studies have shown
that the risk of developing glaucoma increases with the
severity of myopia.11–13 For example, a meta-analysis showed
that the odds ratio (OR) of the association between glaucoma
and low myopia (up to3.00 D) is 1.65 (1.26–2.17), while the
OR of the association between glaucoma and moderate-to-high
myopia (3.00 D) is 2.46 (1.93–3.15).11 On the other hand,
other studies did not find any significant relation between
myopia and POAG. The Ocular Hypertension Treatment Study
did not find an association with POAG for either low (<1.00
D), moderate (1.00 to 3.00 D) or high myopia (<3.00 D)4;
and in a population-based study, Weih et al.12 reported an
association between myopia (0.5 D) and probable glaucoma
but this association was no longer significant when only cases
with definite glaucoma were analyzed. It is important to note
that elongated myopic eyes (as observed in patients with high
myopia) show anatomic and structural changes that are
clinically very challenging to distinguish from those observed
in POAG, which may lead to an overdiagnosis of POAG in
myopic patients. Therefore, up until now, it is not clear
whether myopia is truly a risk factor for glaucoma or not.
Possible mechanisms and theories have been reported.
Hypotheses include connective tissue vulnerability in the optic
nerve of myopic individuals, anatomic changes in myopic eyes
that associate with glaucomatous damage, and elongation of
the ocular axis due to high IOP.13
Genome-wide association studies (GWAS) have identified
161 loci associated with common myopia,14 26 with
POAG,15–22 and more than 60 with quantitative traits or POAG
endophenotypes, such as IOP, vertical cup–disc ratio (VCDR),
and disc and cup area.23 Although only one locus on
chromosome 14 (close to the SIX6 gene), has been consis-
tently found to be associated with both myopia and POAG,
other overlapping genomic regions have been identified
between refractive error and POAG endophenotypes. Those
regions include chromosome 20 close to the BMP2 gene
(refractive error and VCDR), chromosome 2 in proximity to the
EFEMP1 gene (refractive error and cup area), and chromosome
3 proximal to the FNDC3B gene (refractive error and IOP). To
date, the genetic relationship between myopia and POAG has
not been systematically studied.
Given the controversial relationship between both condi-
tions and their polygenicity, we investigated whether common
genetic variants associated with common nonsyndromic
myopia underlie POAG and POAG endophenotypes. To
accomplish this, we used two approaches. In the first
approach, we constructed polygenic risk scores (PRSs) for
myopia using the summary statistics from a meta-analysis of
refractive error,14 and then tested whether the myopia PRSs
were associated with (1) POAG in 798 POAG cases and 1992
controls from the Australian & New Zealand Registry of
Advanced Glaucoma (ANZRAG), and (2) with POAG endophe-
notypes (i.e., IOP, VCDR, cup and disc area) in 11,097
individuals from the Rotterdam Study (RS). As a second
approach, we used summary statistics from the refractive
error meta-analysis,14 and POAG17/POAG endophenotypes23
GWAS meta-analyses, to assess the genetic correlation between
POAG and myopia using the linkage disequilibrium (LD) score
regression method.24
METHODS
Sample Description
This study includes data from two cohorts, ANZRAG and RS.
Both adhered to the tenets of the Declaration of Helsinki and
were approved by their local Medical Ethics Committees. All
participants provided written informed consent.
The Australian & New Zealand Registry of
Advanced Glaucoma (ANZRAG)
ANZRAG is a prospective study of POAG cases that aims to
investigate genetic risk factors contributing to the develop-
ment of glaucoma. The current study included 798 advanced
POAG cases from ANZRAG and 1992 unscreened controls
(drawn from the Australian Cancer Study or a study of
inflammatory bowel diseases) who did not participate in the
GWAS of refractive error conducted by the Consortium for
Refractive Error and Myopia (CREAM). Cases and controls were
drawn from Southern Adelaide Health Service/Flinders Univer-
sity, University of Tasmania, Queensland Institute of Medical
Research, and the Royal Victorian Eye and Ear Hospital.
Definition of advanced POAG in ANZRAG can be found in
the Supplementary Materials. The patient DNA was genotyped
on Illumina, Inc. (San Diego, CA, USA) Omni1M or Omni
Express arrays. The quality control methods were performed in
PLINK (http://www.cog-genomics.org/plink2/) by removing
close relatives (i.e., pihat > 0.2) with more than 3% missing
genotypes, SNPs with call rate < 97%, minor allele frequency
(MAF) < 0.01, and out of Hardy-Weinberg equilibrium (HWE),
as described elsewhere.17 Genotype imputation was per-
formed using 1000 Genomes (http://www.inter
nationalgenome.org/) Phase 1 Europeans as the reference
panel. Additional details regarding genotype quality control
and imputation can be found in Supplementary Table S1. All
participants were Australians of European ancestry.
The Rotterdam Study (RS)
The RS is an ongoing prospective population-based study that
aims to investigate determinants of disease occurrence and
progression in the elderly.25 In this study, data from the RS
were used to investigate the association between PRSs for
common, nonsyndromic myopia and quantitative traits of
POAG, including IOP, VCDR, cup area, disc area, and retinal
nerve fiber layer (RNFL). In brief, the RS started in 1990 and
comprises 7983 subjects 55 years of age or over living in the
Ommoord district in Rotterdam, The Netherlands. Participants
underwent a home interview and an extensive ophthalmologic
examination at baseline with follow-up examinations occurring
every 3 to 4 years (RS-I). The cohort was further extended in
2000 (RS-II) and 2005 (RS-III), establishing a total of 14,926
participants. Of these, 11,097 have available data on POAG-
related quantitative traits. The ophthalmologic assessment
consisted of IOP measurements and optic nerve head
assessment. In a subset of individuals (n¼ 5261), peripapillary
RNFL was measured by optical coherence tomography (OCT).
Details regarding phenotyping can be found in the Supple-
mentary Data and Supplementary Table S2. Genotyping of
SNPs was performed using the Illumina Infinium II Human-
Hap550 array (RS-I), the Illumina Infinium HumanHap 550-Duo
array (RS-I, RS-II), and the Illumina Infinium Human 610-Quad
array (RS-I, RS-III). Samples with low call rate (<97.5%), with
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excess autosomal heterozygosity (>0.336), or with sex
mismatch were excluded, as were outliers identified by the
identity-by-state (IBS) clustering analysis; outliers were defined
as being >3 standard deviations (SD) from population mean or
having IBS probabilities >97%. Further information on
genotyping and imputation for both ANZRAG and RS is also
provided in the Supplementary Table S1.
Calculation of PRS
PRSs of myopia were computed using the summary statistics
from the GWAS meta-analysis conducted by CREAM and the
personal genomics company 23andMe, Inc. (Mountain View,
CA, USA) (combined n ¼ 160,420).14 Given that the RS was
included in the CREAM meta-analysis, we used the summary
statistics from the GWAS meta-analysis excluding RS-I, RS-II,
and RS-III (n ¼ 10,775). To calculate the PRS, we considered
only autosomal variants with a high imputation quality
(IMPUTE info score > 0.5 or minimac Rsq > 0.8) and a MAF
> 1%. We then performed a P value-based clumping in PLINK
excluding the MHC region and using an r2 threshold of 0.2 and
a physical distance threshold of 500 kb. This resulted in a total
of 243,938 variants. In total, 12 scores were generated using
the –score command in PLINK (v1.9) across strata of increasing
liberal P value thresholds (score categories): 5.03 108, 5.03
107, 5.03 106, 5.03 105, 5.03 104, 0.005, 0.01, 0.05, 0.1,
0.5, 0.8, and 1.0. The number of SNPs in each P value category
can be found in Supplementary Table S3. For each individual in
RS-I, RS-II, and RS-III (n¼ 10,792) and ANZRAG (n cases¼ 798
and n controls¼1992), 12 scores were calculated. Distribution
of the PRS in each study can be found in Supplementary Figure
S1, whereas the distribution of refractive error in the RS is
shown in Supplementary Figure S2. To assess the predictive
ability of the scores we tested the association of the
constructed 12 PRSs for myopia with axial length (one of the
major optical components of the eye) in the RS.
Statistical Analysis
Association of Myopia PRS With POAG. In order to
evaluate whether PRS for myopia can explain variation in
POAG susceptibility, we regressed the derived myopia PRS on
the POAG outcome under a logistic model. The models were
adjusted for sex and the first five ancestral principal
components. The ANZRAG study was initially designed to
ascertain glaucoma cases. Prior to our analyses, we excluded
358 ANZRAG participants who were included in the CREAM
myopia GWAS meta-analysis to prevent bias in our estimates
due to sampling overlap. The strength of the association
between each of the 12 PRSs for myopia and POAG was
assessed via the pseudo-R2 (proportion of variance on POAG
explained by myopia PRS) approach.
Association of Myopia PRS With POAG Quantitative
Traits. We further assessed the association between the 12
PRSs for myopia with IOP (n ¼ 11,097), three optic disc
parameters to include VCDR (n ¼ 10,433), cup area (n ¼
10,404) and disc area (n ¼ 10,418), and RNFL measured by
OCT (n¼ 2215) using linear regression. In total, 1.68% (187/
11,097) of the participants from the RS received IOP-lowering
medication (see Supplementary Table S4); in those individu-
als, we added 30% to the IOP measurement to estimate a
premedication IOP value.26 We excluded from the analysis
those patients who underwent IOP-lowering laser or surgery.
IOP and optic disc parameter analyses were corrected for age,
sex, the first five principal components, and cohort. Disc area
analyses were not corrected for eye size effect, as the main
purpose of this study was to investigate whether there is an
association between the PRSs for myopia and optic disc
parameters. For the RNFL analysis, we excluded participants
with age-related macular degeneration, cataract, aphakia, or
pseudophakia, and scans with poor quality (i.e., image quality
value < 45) as previously reported.27 RNFL analyses were
corrected for age, sex, the first five principal components,
cohort, and OCT device, and an extra analysis including axial
length was also performed. The proportion of variance
explained by each PRS was calculated as the difference of
R2 in the full model as compared with the null model, which
included the previously mentioned covariates but not the
polygenic score. P values were determined from likelihood
ratio tests, which compared the full model with the null
model. Given the known relation between high myopia
6.00 D and POAG, we ran the same analyses in a subset of
individuals of the RS with high myopia (6.00 D, n ¼ 232),
and with moderate myopia (5.99 to3.00 D, n¼771). Given
the limited number of participants with OCT data available,
RNFL was not analyzed in the subgroup of individuals with
high and moderate myopia. In the RS, we analyzed 12 PRSs in
three subgroups (i.e., high myopia, moderate myopia, and all),
and two categories of phenotypes (IOP and optic disc
parameters). In addition, we tested whether the 12 PRSs
were associated with RNFL in a subgroup of the RS with OCT
data available, for a total of 84 tests in the RS. In ANZRAG we
explored 12 PRSs. Hence, we set our Bonferroni-corrected
threshold to 5.2 3 104 (0.05/96). All regression analyses in
ANZRAG and RS were performed using the statistical package
R (version 3.3.3; R Foundation for Statistical Computing,
Vienna, Austria).
LD Score Regression
Cross-trait LD score regression method was used to assess the
genetic overlap between myopia and POAG, including POAG
quantitative traits. GWAS summary statistics from the Europe-
ans-only meta-analyses14,23,17 were used to estimate genetic
correlation between pairs of traits using the LD score
regression program.24,28 To restrict the analyses to well-
imputed SNPs, we included only SNPs with MAF > 0.01 that
were present in HapMap3. More details can be found in the
Supplementary Materials. We set our Bonferroni-corrected
threshold to 0.05/5 ¼ 0.01 (correction for myopia versus
POAG, VCDR, IOP, and cup and disc area).
RESULTS
Table 1 shows the characteristics of both studies. We tested the
ability of the calculated PRSs for myopia to predict axial length.
The calculated PRSs for myopia explained up to 6.1% of the
variance of axial length. We observed that the prediction
accuracy demonstrated plateauing at a P value threshold of 0.5
(see Supplementary Table S5).
Polygenic Risk Score Analyses
Association of PRSs With POAG in the ANZRAG Study.
Table 2 summarizes the association of myopia PRSs on POAG.
None of the myopia PRSs were significantly associated with
POAG. Our result showed that genetic predisposition on
refractive error did not predict POAG status, as shown with the
close-to-zero estimated pseudo-R2 results for all PRS categories
(R2 range, 1.43 104–2.03 105).
Association of PRSs With POAG Endophenotypes in
the Rotterdam Study. The association between PRSs for
myopia and POAG endophenotypes is shown in Table 2.
Among the POAG endophenotypes evaluated, the association
between PRSs for myopia and disc area was the strongest
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(highest R2 0.27%, P value¼ 1.63 109). We found suggestive
associations between PRSs for myopia and IOP with an average
R2 of 0.02%, although these associations were not significant
after multiple testing adjustments (lowest P value ¼ 0.01).
Suggestive associations were also observed between PRSs for
myopia and RNFL (Table 3) with an average R2 of 0.13%
(lowest P value ¼ 4.5 3 103). To further investigate if the
nominal association between PRSs for myopia and RNFL was
driven by participants with glaucoma, we removed from the
analyses individuals with glaucomatous visual field loss (GVFL),
and observed that the results did not change (average R2 of
0.14%, lowest P value¼7.73103). None of these associations
surpass our Bonferroni correction threshold of 5.23 104.
We further studied the association between the PRSs for
myopia and POAG only in individuals from the RS with high
myopia (6 D, n¼232) and moderate myopia (5.99 to3.00
D, n ¼ 771); see Supplementary Tables S6 and S7. In these
analyses, we did not observe an association between PRSs for
TABLE 1. Demographics and Ocular Characteristics in the ANZRAG and the Rotterdam Study
Study n % Men
Controls
(Cases)
Cases With
Missing Data Mean (SD) Age Range
Case–control study
POAG age at diagnosis
ANZRAG (excl. CREAM) 2790 40.30 1992 (798) 256 59 (14.2) 16–90
Intraocular pressure*
ANZRAG 2790 40.30 1992 (798) 101 27 (10.4) 10–78
Study n % Men Mean (SD) Range Mean Age (SD) Age Range
Population-based study
Intraocular pressure
RS-I 6010 40.30 14.7 (3.2) 5.0–28.6 69.2 (9.0) 55–101
RS-II 2095 45.90 14.2 (3.1) 7.0–31.5 64.8 (7.9) 55–95
RS-III 2992 43.70 13.6 (2.9) 4.5–30.0 57.2 (6.8) 46–97
Vertical cup–disc ratio
RS-I 5573 40.90 0.50 (0.13) 0.05–0.87 68.0 (8.4) 55–99
RS-II 1987 46.10 0.50 (0.13) 0.10–0.86 64.7 (7.7) 55–96
RS-III 2873 43.90 0.29 (0.21) 0.00–1.00 57.2 (6.6) 46–90
Cup area
RS-I 5555 40.90 0.61 (0.34) 0.01–1.98 68.0 (8.4) 55–99
RS-II 1979 46.00 0.57 (0.32) 0.03–1.94 64.7 (7.7) 55–96
RS-III 2870 43.80 0.40 (0.30) 0.00–1.90 57.2 (6.6) 46–90
Disc area
RS-I 5563 41.00 2.42 (0.47) 0.58–5.13 68.0 (8.4) 55–99
RS-II 1983 46.10 2.33 (0.46) 1.13–5.19 64.7 (7.7) 55–96
RS-III 2872 43.80 1.92 (0.40) 0.75–4.22 57.2 (6.6) 46–90
* Due to ANZRAG’s cohort design, IOP measurements were estimated among cases only and were obtained prior to any treatment.
TABLE 2. Association of PRSs for Myopia and POAG Endophenotypes
Score
META GWAS
P Value
Threshold
POAG Case/Control POAG Quantitative Traits
POAG IOP VCDR Disc Area Cup Area
P Pseudo-R2 P
% Variance
Explained P
% Variance
Explained P
% Variance
Explained P
% Variance
Explained
Reference NA 2.07 NA 26.66 NA 19.50 NA 7.04
S1 5.0 3 108 0.81 1.7 3 105 0.08 0.02 0.42 * 1.6 3 109 0.27 0.25 0.003
S2 5.0 3 107 0.50 1.4 3 104 0.10 0.02 0.44 * 9.1 3 108 0.21 0.45 *
S3 5.0 3 106 0.49 1.4 3 104 0.03 0.03 0.29 * 7.7 3 107 0.18 0.52 *
S4 5.0 3 105 0.42 2.0 3 104 0.01 0.05 0.63 * 1.7 3 106 0.17 0.86 *
S5 5.0 3 104 0.78 2.3 3 105 0.02 0.04 0.42 * 1.8 3 108 0.24 0.45 *
S6 0.005 0.48 1.5 3 104 0.02 0.04 0.72 * 3.2 3 105 0.13 0.74 *
S7 0.01 0.83 1.3 3 105 0.05 0.02 0.69 * 4.1 3 105 0.12 0.62 *
S8 0.05 0.70 4.4 3 105 0.29 0.00 0.64 * 2.4 3 104 0.10 0.68 *
S9 0.1 0.56 1.0 3 104 0.25 0.00 0.73 * 2.2 3 103 0.06 0.96 *
S10 0.5 0.52 1.3 3 104 0.16 0.01 0.78 * 2.9 3 103 0.06 0.82 *
S11 0.8 0.52 1.3 3 104 0.17 0.01 0.66 * 4.4 3 103 0.06 0.75 *
S12 1 0.51 1.3 3 104 0.17 0.01 0.67 * 4.2 3 103 0.06 0.77 *
P, P value of the association of the PRS for myopia with POAG and the studied POAG endophenotype, pseudo-R2 %, and % variance explained;
percentage of the variance of POAG or the studied POAG quantitative trait explained by the PRS for myopia. Reference model does not include the
PRS. Boldface font: PRSs showing a significant association at a Bonferroni-corrected P value of P < 5.23 104. NA, not applicable.
* PRS in which the tested model does not improve the variance explained compared to the reference model.
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myopia and disc area (as previously observed), but we found a
suggestive association with IOP in the high myopia group
(average R2 of 0.72%, lowest P value ¼ 0.01).
LD Score Regression Results
The results of our bidirectional linkage disequilibrium score
regression (LDSC) analyses between POAG and its endophe-
notypes are shown in Table 4. Consistent with our PRS
findings, we did not find evidence for a genetic correlation
(RhoG) between refractive error (myopia) and most POAG
endophenotypes, except for disc area (RhoG ¼ 0.12, SE ¼
0.04. P value ¼ 1.8 3 103). We did estimate the genetic
correlation between refractive error and POAG (RhoG¼0.2, SE
¼ 0.72, P value ¼ 0.78) although the standard error is large,
which does not allow far-stretching inferences.
DISCUSSION
In this study, we evaluated whether the reported epidemio-
logic association between myopia and POAG can be explained
by a shared common polygenic structure. We used two large
cohorts (a population-based study, the RS, and a case/control
POAG cohort, ANZRAG), and publicly available GWAS summa-
ry statistics. Using both the classical PRS approach and the LD-
score regression method, we found that genetic predisposition
of myopia in the general population shows no strong
association with POAG susceptibility. However, we found a
robust genetic overlap between myopia and both axial length
and optic nerve disc area, which supports our methodology,
given that axial length is a major optical component and
determinant of refractive error, and that the disc area increases
proportionately with refractive error29–31 and are therefore
directly related.
There is vast epidemiologic evidence from case–control or
cross-sectional studies that supports the comorbidity between
myopia and POAG.11,32–35 For example, it has been reported
that 6% to 29% of POAG patients have myopia,32 and
population-based studies have shown that the odds of
developing POAG are higher with increasing severity of
myopia.11,32 However, the evidence from randomized con-
trolled trials, other population-based studies, and incidence
studies is conflicting. The Ocular Hypertension Treatment
Study did not find an association between myopia and POAG,6
nor did an incidence study in Korea36 or a population-based
study in which myopia was associated only with probable but
not with definite POAG.12 However, several other incidence
studies support the association between myopia and
POAG.37,38 Furthermore, it is important to note that the
clinical differentiation between early-stage glaucoma and
myopic changes ‘‘that look like glaucoma’’ is challenging. As
the discs of myopic eyes might appear with large-diameter
cups and nerve fiber layer defects, these findings can lead to
misclassification of glaucoma in myopic eyes.39 It has been also
argued that if myopia was a risk factor for POAG, myopia
should also modulate visual field loss, and therefore myopia
should be associated with POAG severity, which has not been
found in other studies.40,41 Our study assessing the genetic
overlap between the two conditions, in European-descent
TABLE 3. Association of PRSs for Myopia and RNFL Measured by OCT
Score
GWAS P
Threshold
All Participants (n ¼ 2215)
Excluding People
With GVFL (n ¼ 2136)
P
% Variance
Explained P
% Variance
Explained
Reference NA NA
S1 5.0 3 108 6.31 3 102 0.0662 7.19 3 102 0.063
S2 5.0 3 107 9.60 3 102 0.0478 9.35 3 102 0.051
S3 5.0 3 106 1.77 3 102 0.1249 1.84 3 102 0.128
S4 5.0 3 105 2.31 3 102 0.1123 2.54 3 102 0.113
S5 5.0 3 104 4.56 3 103 0.1899 7.82 3 103 0.171
S6 0.005 4.81 3 103 0.1873 7.75 3 103 0.172
S7 0.01 8.88 3 103 0.1576 1.05 3 102 0.157
S8 0.05 6.83 3 103 0.1703 1.14 3 102 0.152
S9 0.1 5.44 3 103 0.1813 8.70 3 103 0.166
S10 0.5 1.27 3 102 0.1407 1.17 3 102 0.151
S11 0.8 1.21 3 102 0.1427 1.16 3 102 0.151
S12 1 1.22 3 102 0.1422 1.17 3 102 0.151
P , P value of the association of the PRS for myopia with RNFL. Reference model does not include the PRS.
TABLE 4. Results of the Genetic Correlation Between Myopia, POAG, and POAG Endophenotypes Using the LDSC Method
Trait 1 Trait 2 RhoG SE of RhoG P Value
Myopia and POAG
Myopia META GWAS POAG 0.2 0.72 0.78
Myopia and POAG endophenotypes
IGGC IOP Myopia META GWAS 0.04 0.05 0.44
IGGC VCDR Myopia META GWAS 0.05 0.04 0.17
IGGC cup area Myopia META GWAS 0.01 0.04 0.78
IGGC disc area Myopia META GWAS 0.12 0.04 1.80 3 103
Boldface font: genetic correlation showing a significant association at a Bonferroni-corrected P value of P < 0.01. IGGC, International Glaucoma
Genetics Consortium.
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populations, supports the results from studies in which no
relationship between myopia and POAG was found.
The lack of association between myopia and VCDR
(reported in this study and tested using two different
approaches) has also been described by Qiu et al.,42 in a
cross-sectional study that included a representative sample
from the US population. The authors found that the adjusted
odds of VCDR > or ¼ 0.7 were not significantly increased in
subjects with mild, moderate, or severe myopia.42 However, in
the same study, the authors observed an association between
visual field defects and myopia.
Although we did not find an association between myopia
and POAG, we did observe a nominal association between PRSs
for myopia and IOP in the high myopia subgroup, and a
nominal association between PRSs for myopia and RNFL. The
association with IOP might be in line with previous studies, in
which it has been reported that myopic eyes have a slightly
higher IOP and a thinner central corneal thickness than
emmetropic eyes. It has been suggested that myopia could
mediate the risk of POAG through weaker scleral support.39
Interestingly, a study examining the joint effect of IOP and
myopia on the risk of POAG found that individuals with high
IOP and moderate-to-high myopia had approximately 4.5-fold
increased risk of POAG compared with individuals without
myopia and with relatively lower IOP.43 Regarding the nominal
association with RNFL, various studies have investigated the
association between various optic nerve head (ONH) param-
eters measured by OCT and refractive error40,41,44 and have
consistently reported a significant association between RNFL
and refractive error. However, it has also been described that
OCT machines do not take into account individual retinal
anatomy variation, which may lead to diagnostic biases toward
optic neuropathies, particularly in patients with refractive
errors.41 Furthermore, these studies40,41 have shown that the
association between RNFL and refractive error is independent
of glaucoma severity. Hence, the nominal association observed
between the PRSs for myopia and RNFL, rather than a truly
biological association, represents the bias observed in enlarged
eyes measured by OCT. In line with this notion, when we
adjusted our model for axial length, the PRSs for myopia were
not associated with RNFL (average R2 ¼ 9.43 105, P value ¼
0.41, Supplementary Table S8).
Our study has several notable strengths. Firstly, our POAG
phenotypes were obtained through clinical diagnosis and
hence are free from self-reporting biases. Secondly, given the
advance definition of POAG in ANZRAG, POAG misclassifica-
tion due to high myopia is unlikely. Thirdly, our myopia PRSs
capture almost 8% of the heritability on myopia (h2 0.71),45
showing that these PRSs are good proxies for genetic
predisposition on myopia, and we found a genetic overlap
between myopia and both axial length and disc area, which
also validates our methodology. Finally, we used two different
methods (i.e., PRS and LDSC) to evaluate the genetic overlap
between these two disorders. LDSC allows meaningful
interpretation of the genetic correlations without worrying
about biases arising from cryptic relatedness and population
stratification that might be present in PRS studies.
There are also limitations that ought to be considered when
interpreting these findings. Since both ANZRAG and RS, as well
as the CREAM meta-analysis, consist mainly of individuals of
European ancestry, it is unclear whether our findings are
generalizable to other populations. Both the PRS approach and
LD-score regression evaluate shared genetic architecture from
common variants; this, in turn, does not invalidate the
presence of very rare variants that may exert large effects on
both myopia and POAG. Hence, our inference is limited to the
general population, which might not necessarily be compatible
with findings from family-based eye disorders studies of rare
variants. Further, the current knowledge on the genetic
etiology of both disorders is limited, which also restricts our
conclusions. Due to sample size concerns, we did not perform
causal inference analyses such as Mendelian randomization
(MR) to evaluate the direction of causality between myopia,
POAG, and its endophenotypes. However, the lack of evidence
for a shared genetic architecture eludes two possibilities: (1)
our statistical power might be insufficient for MR and/or (2)
the underlying causal relationship between myopia and POAG
(and its endophenotypes) is likely to be null. In short, larger
sample sizes are warranted to make robust claims about
causality. In conclusion, we did not find evidence to support a
genetic association between myopia and POAG. Taken
together, our findings suggest that the shared genetic
architecture between myopia and POAG in the general and
European-descent population is likely to be limited.
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